



Kim et al. Cardiovascular Diabetology  (2015) 14:74 
DOI 10.1186/s12933-015-0238-8ORIGINAL INVESTIGATION Open AccessAssociation of insulin resistance and
coronary artery remodeling: an intravascular
ultrasound study
Sang-Hoon Kim1, Jae-Youn Moon1*, Yeong Min Lim1, Kyung Ho Kim1, Woo-In Yang1, Jung-Hoon Sung1,
Seung Min Yoo2, In Jai Kim1, Sang-Wook Lim1, Dong-Hun Cha1 and Seung-Yun Cho1Abstract
Background: There are few studies that investigated the correlation between insulin resistance (IR) and the coronary
artery remodeling. The aim of the study is to investigate the association of IR measured by homeostasis model
assessment of insulin resistance (HOMA-IR) and coronary artery remodeling evaluated by intravascular ultrasound (IVUS).
Methods: A total of 298 consecutive patients who received percutaneous coronary interventions under IVUS
guidance were retrospectively enrolled. The value of HOMA-IR more than 2.5 was considered as IR positive. Metabolic
syndrome was classified according to NCEP ATP III guidelines. The remodeling index was defined as the ratio of the
external elastic membrane (EEM) area at the lesion site to the EEM area at the proximal reference site.
Results: A total of 369 lesions were analyzed (161 lesions in HOMA-IR positive and 208 lesions in HOMA-IR negative).
Remodeling index was significantly higher in the HOMA-IR positive group compared with the negative group
(HOMA-IR positive vs. negative: 1.074 ± 0.109 vs. 1.042 ± 0.131, p = 0.013). There was a significant positive correlation
between remodeling index and HOMA-IR (p = 0.010). Analysis of HOMA-IR according to remodeling groups showed
increasing tendency of HOMA-IR, and it was statistically significant (p = 0.045). Multivariate analysis revealed that only
HOMA-IR was an independent predictor of remodeling index (r = 0.166, p = 0.018).
Conclusion: Increased IR estimated by HOMA-IR was significantly associated with a higher remodeling index and
positive coronary artery remodeling.
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Coronary artery remodeling is changes in the external
elastic membrane (EEM), typically occurred in response
to atherosclerotic plaque accumulation. Positive remodel-
ing (PR) refers to a larger EEM area at a lesion site than
the adjacent reference site, and negative remodeling (NR)
refers to a smaller EEM area than the adjacent reference
site. Several studies have demonstrated that PR is more
predominant in patients with acute coronary syndrome
(ACS) comparing to patients with stable angina pectoris
[1–3]. Previous study have reported that a PR lesion has
higher lipid contents and a macrophage count, both* Correspondence: answod77@naver.com
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creativecommons.org/publicdomain/zero/1.0/markers of plaque vulnerability in a necropsy study [4]. It
is also known that NR is a common finding in diabetic pa-
tients and is associated with several factors like smoking,
hypertension and plasma homocysteine levels [5–7]. Ad-
vanced glycation end-products are known as key sub-
stances involved in the negative remodeling associated
with diabetes. Smoking causes endothelial dysfunction, in-
creased oxidative stress, and decreased nitric oxide syn-
thesis leading to inward remodeling [8].
Insulin resistance (IR) is mediated by the interaction of a
person’s genetic characteristics and acquired pathophysio-
logic insults by personal lifestyle. Molecular studies demon-
strated that IR has a key role in every stage of
atherosclerosis from the initiation to the clinically signifi-
cant progression of plaques [9]. Previous studies reported
that IR was associated with the coronary artery calciumle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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However, there are few reports that investigated the
correlation of IR or metabolic syndrome (MetS) with the
coronary artery remodeling. In this study, we investigated
the association between IR measured by homeostasis model
assessment of insulin resistance (HOMA-IR) and coronary
artery remodeling by intravascular ultrasound (IVUS).
Methods
Patient population
This study was retrospectively conducted with patients who
received percutaneous coronary intervention (PCI) under
IVUS guidance for de novo coronary artery lesions in Bun-
dang CHA medical center between January 1st and Decem-
ber 31st in 2010. Exclusion criteria were patients whose
images of IVUS were inadequate for analyses due to severe
calcification (with an arc of > 90° of acoustic shadowing,
n = 28) or poor image (n = 7) and patients with severe calci-
fication in whom IVUS catheter could not pass the target
lesion before stenting (n = 16). Subjects whose IVUS study
was done only after stenting (n = 49) were also excluded.
Among 398 patients who received PCI, 369 lesions of 298
patients were selected and divided into IR positive and
negative groups. The diagnosis of ACS was made in accord-
ance with the definition of myocardial infarction revised by
the European Society of Cardiology/American College of
Cardiology in 2000 [13]. The study protocol was approved
by the institutional review board of our hospital.
IVUS imaging and analyses and definitions of remodeling
Two IVUS systems, a 20-MHz, 2.9 F IVUS system (Eagle
Eye, Volcano Corp, Rancho Cordova, CA, USA) and a 40-
MHz, 2.6 F IVUS system (Atlantis SR Pro, Boston Scientific
Corp, Fremont, CA, USA) were used in this study. The
IVUS catheter was advanced >10 mm beyond the lesionFig. 1 Example case of patient with insulin resistance. Seventy six year-old
positive remodeling of proximal right coronary artery was demonstrated. T
(arrow b, panel b, 24.3 mm2) divided by reference EEM (arrow a, panel a, 1and automated pullback was performed to the aorto-ostial
junction at a speed of 0.5 mm/s. For every patient, the tar-
get lesion site and a proximal reference site were selected
for measurement. The target lesion was defined as the site
with the smallest minimal lumen diameter (MLD) or rup-
tured plaque. The proximal reference segment was chosen
as the site with the least amount of plaque proximal to the
target lesion without any intervening side branch.
Coronary artery remodeling was defined by comparing
the EEM area at the lesion site to the EEM area at the
proximal reference site. The remodeling index was
defined as the ratio of the EEM area at the lesion site to
the EEM area at the proximal reference site in this study
(Fig. 1). Patterns of arterial remodeling were classified
into three categories; positive remodeling was defined as
a remodeling index >1.05; intermediate remodeling as a
remodeling index between 0.95 and 1.05; negative re-
modeling as a remodeling index <0.95 [3, 14].
Classification of metabolic syndrome and insulin resistance
The status of IR was measured using HOMA-IR, with
the following formula; HOMA-IR = fasting insulin (μIU/
mL) × fasting glucose (mmol/L)/22.5. The presence of
MetS was defined by the NCEP ATP III guidelines [15].
MetS scores, ranged from 0 to 5 points, were calculated
according to the number of MetS components. Patients
whose values exceeded 2.5 of HOMA-IR were consid-
ered as an IR positive [16].
Intra-observer and inter-observer variabilities of IVUS
analysis
Two expert operators blinded to the clinical presentation
analyzed the IVUS images, and parameters for analysis
were presented as the means of both measured parameters.
Quantitative measurements of the IVUS images of EEMman who received PCI due to ST elevation myocardial infarction. The
he remodeling index was 1.373 which was calculated by lesion EEM
7.7 mm2)
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off-line IVUS analysis system. The correlation coefficient
obtained from linear regression analysis and the percent
error obtained by calculating the absolute difference divided
by the initial measurements [17]. In our institution, the
intra-observer correlation coefficient and percent error for
EEM were 0.97 and 4.2 ± 4.6 %, respectively, and the inter-
observer correlation coefficient and percent error for EEM
were 0.95 and 5.2 ± 5.3 %, respectively.
Statistical analyses
Statistical analyses were performed using the SPSS 19.0
version. Quantitative data was presented as mean ± SD
and compared by Student’s t-test or Fisher’s exact test
when at least 25 % of values showed an expected fre-
quency <5. One-way ANOVA with the multiple compar-
isons between the remodeling groups was done with
post hoc Tamhane test. p < 0.05 was considered to be
significant. To measure the strength of association be-
tween two continuous variables, Pearson correlation
analysis was used. Using an epidemiological approach,
multivariable linear regression analysis was performed toTable 1 Baseline characteristics of study population
Characteristics Total (n = 298) HOMA n
Age (years) 62.6 ± 11.2 62
Male 202 (67.8) 114 (67.9
Waist Circumference (cm) 89.6 ± 8.2 88
BMI (Kg/m2) 24.8 ± 3.1 24
Hypertension 189 (63.4) 93 (55.4)
Current smoker 141 (47.3) 80 (47.6)
Diabetes Mellitus 89 (29.9) 35 (20.8)
Previous MI 16 (5.4) 9 (5.4)
Previous CVA 11 (3.7) 7 (4.2)
Acute coronary syndrome 148 (49.7) 78 (46.4)
Number of diseased vessels
One 105 (35.2) 65 (38.7)
Two 101 (33.9) 54 (32.1)
Three 92 (30.9) 49 (29.2)
Metabolic syndrome score 2.13 ± 1.14 1.
Total cholesterol (mg/dL) 178.9 ± 46.4 177
Triglycerides (mg/dL) 144.5 ± 90.5 134
HDL-C (mg/dL) 42.1 ± 10.2 43
LDL-C (mg/dL) 105.5 ± 39.4 106
HbA1C (%) 6.56 ± 1.33 6.
NT-proBNP (pg/ml) 1233.4 ± 5065.4 562
hsCRP (mg/dl) 0.53 ± 1.18 0.
LV Ejection fraction (%) 55.7 ± 12.9 56
Values are presented as mean ± SD or number (%)
MetS metabolic syndrome, BMI body mass index, MI myocardial infarction, CVA cere
LV left ventricleidentify independent predictors of remodeling index by
means of a backward stepwise model. Variables associ-
ated with remodeling index with a p-value less than 0.05
in the univariate analysis or clinically relevant variables
were entered into the multivariable model.
Results
Baseline characteristics
A total of 298 patients were included in the study and
divided into patients with HOMA-IR positive group
(130 patients, 43.6 %) and HOMA-IR negative group
(168 patients, 56.4 %). Patient’s clinical and laboratory
characteristics according to HOMA-IR groups are shown
in Table 1. The mean age was 62.6 ± 11.2 years and
67.8 % were men. There were no significant differences
in age, gender, smoking history, previous history of MI,
CVA and percentage of ACS between the HOMA-IR
positive group and negative group. The components of
MetS (BMI, hypertension, diabetes, triglycerides and
HDL-cholesterol) and MetS score were significantly dif-
ferent between the groups. In laboratory tests, there were
no significant differences in hsCRP between the groupsegative (n = 168) HOMA positive (n = 130) p-value
.0 ± 10.8 63.2 ± 11.6 0.357
) 88 (67.7) 0.976
.6 ± 8.9 91.2 ± 6.8 0.075











74 ± 1.09 2.63 ± 1.00 <0.001
.6 ± 46.7 180.7 ± 46.3 0.564
.4 ± 84.2 157.5 ± 96.9 0.029
.5 ± 10.6 40.3 ± 9.3 0.006
.0 ± 1.5 104.7 ± 36.5 0.772
28 ± 1.10 6.95 ± 1.51 <0.001
.3 ± 1356.7 2153.7 ± 7562.8 0.043
47 ± 1.02 0.61 ± 1.36 0.336
.1 ± 12.4 55.1 ± 13.5 0.494
brovascular accident, NT-proBNP N-terminal pro-brain natriuretic peptide,
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the HOMA-IR positive group.
Relation between remodeling index and IR
Comparison of angiographic and IVUS parameters be-
tween HOMA-IR positive and negative by lesion were
presented in Table 2. A total of 369 lesions were ana-
lyzed (161 lesions in HOMA-IR positive and 208 lesions
in HOMA-IR negative). Remodeling index was signifi-
cantly higher in the HOMA-IR positive group compared
with the negative group (HOMA-IR positive vs. negative:
1.074 ± 0.109 vs. 1.042 ± 0.131, p = 0.013) (Fig. 2a). When
the patients were categorized into three groups of posi-
tive, intermediate and negative remodeling, there was a
tendency that the HOMA-IR positive group had more
patients with PR and the HOMA-IR negative group had
more patients with NR, but the difference was not
statistically significant (p = 0.057) (Table 2). Pearson
correlation analysis showed that there was a signifi-
cant positive correlation between remodeling index and
HOMA-IR (correlation coefficient = 0.170, p = 0.010). The
comparison of metabolic indexes among 3 remodeling
groups is presented in Table 3. In this analysis, one culprit
lesion per patient has been analyzed. There are statis-
tically significant difference of HOMA-IR among remod-
eling groups (p = 0.045) (Fig. 2b). The level of hsCRP was
also different among remodeling groups (p = 0.045). MetS
score showed a similar tendency but there are no statis-
tical significance (p = 0.051) (Table 3).
Independent factors affecting remodeling index
The common cardiovascular risk factors and metabolic
factors were tested as potential predictors of remodeling
index (dependent variable) in a regression analysis. Uni-
variate linear regression analysis revealed that presence
of MetS and HOMA-IR were independently associated
with an increase in remodeling index. Other clinical risk
factors (age, sex, smoking history, hsCRP, LDL-C) except
components of MetS were not associated with the
remodeling index.Table 2 Comparison of IVUS parameters between HOMA-IR negativ
Characteristics Total n = 369 lesions HOMA-IR nega
Reference EEM area (mm2) 14.96 ± 5.27 15.0
Lesion EEM area (mm2) 15.05 ± 5.00 15.0
Lesions per patient 1.23 ± 0.47 1.2
Remodeling index 1.056 ± 0.123 1.04
Remodeling patterns
Positive remodeling 185 (50.1) 97 (46.6)
Intermediate remodeling 124 (33.6) 69 (33.2)
Negative remodeling 60 (16.3) 42 (20.2)
Values are presented as mean ± SD or number (%)
IVUS intravascular ultrasound, MetS metabolic syndrome, EEM external elastic membMultivariate analysis was performed to identify inde-
pendent factors affecting remodeling index. Multivari-
ate analysis with linear regression analysis by age, sex,
smoking, the presence of MetS and HOMA-IR was per-
formed. Multivariate analysis showed only HOMA-IR was
an independent predictor of remodeling index (r = 0.166,
p = 0.018) (Table 4).
Discussion
Positive remodeling and vulnerable plaque
The PR may attenuate the encroachment of the plaque
into the lumen, thereby maintaining the lumen area,
thus it was thought of arterial enlargement as a benefi-
cial response and negative remodeling as a harmful re-
sponse to atherosclerotic plaque formation. However,
histopathological studies clearly demonstrated that PR is
associated with infiltration of inflammatory cells, expres-
sion of pro-inflammatory cytokines, and increased prote-
ase activity [4, 18].
Moreover, a recently developed virtual histology (VH)-
IVUS have facilitated accurate in vivo analysis of coronary
plaque and showed that PR is associated with a greater
plaque volume and a greater necrotic core [19–21]. There-
fore, large plaque burden with increased vessel diameter
(PR) determined by IVUS study would be a significant risk
factor for rupture of coronary plaques. A recent study of
serial IVUS and optical coherence tomography (OCT)
showed that positive arterial remodeling was related to
thinning change of the fibrous cap [22]. Therefore, it is
clear that PR is associated with vulnerable plaque and pro-
gression of atherosclerosis.
Vulnerability of coronary atherosclerotic plaques plays
a significant role in the occurrence of ACS. It still
remains unclear what morphological features will best
predict plaque rupture and which diagnostic technolo-
gies would reliably predict the pathological and clinical
courses of a vulnerable plaque. It also remains unclear
what treatment would improve or change the character-
istics of coronary plaques. Several study focused the
vulnerability and plaque regression [23, 24]. Therefore,e and HOMA-IR positive groups
tive n = 208 lesions HOMA-IR positive n = 161 lesions P-value
5 ± 5.68 14.84 ± 4.72 0.711
6 ± 5.14 15.04 ± 4.82 0.977
4 ± 0.47 1.22 ± 0.47 0.703






Fig. 2 a. Remodeling index was significantly higher in the HOMA-IR positive group compared with the negative group (HOMA-IR positive vs.
negative: 1.074 ± 0.109 vs. 1.042 ± 0.131, p = 0.013). b. Relation of remodeling group with HOMA-IR. The level of HOMA-IR is positively correlated
with remodeling group (p = 0.045 by analyses of one-way ANOVA; NR vs. IR, p = 0.703; NR vs. PR, p = 0.023; IR vs. PR, p = 0.176 by post hoc test).
(NR; negative remodeling, IR; intermediate remodeling, PR; positive remodeling)
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important clinical goal for the prevention of catastrophic
events like ACS or sudden death and can be a guide for
an adjunctive medical or device-based treatment plan.
Insulin resistance and coronary artery remodeling
Diabetes mellitus is known as a high risk factor for ACS
or coronary artery stenosis even though PR is not fre-
quently observed in them [5, 6]. Moreover, underlying
pathophysiological determinants that induce negative
remodeling in diabetes remain unclear. The IR has been
thought as a main cause of type 2 diabetes and MetS.
Emerging evidences support a direct proatherogenic
effect of IR on the coronary arteries and the advances of
understanding molecular mechanisms for atherosclerosis
support these findings [9, 25].
Aggravation of IR may be atherogenic via several
mechanisms independent of hyperglycemia [26]. More-
over, hyperinsulinemia and IR probably have severalTable 3 Comparison of metabolic indexes by remodeling patterns
Characteristics Negative remodeling Inter
n = 50 n = 9
Age (years) 62.18 ± 10.25
Male 40 (66.7) 81 (6
Waist Circumference (cm) 88.5 ± 7.3
BMI (Kg/m2) 24.8 ± 2.7
Total cholesterol (mg/dL) 178.0 ± 48.2
Triglycerides (mg/dL) 138.0 ± 82.4
HDL-C (mg/dL) 43.3 ± 10.3
LDL-C (mg/dL) 100.6 ± 38.8
HbA1C (%) 6.56 ± 1.54
hsCRP (mg/dl) 0.16 ± 0.27
HOMA-IR 2.38 ± 1.80
MetS Score 1.78 ± 0.97
Values are presented as mean ± SD or number (%)
BMI body mass index, MetS metabolic syndrome, hsCRP high sensitivity C-reactive patherogenic effects, including the promotion of inflam-
mation and endothelial dysfunction. There are some re-
ports that patients with hyperinsulinemia may have
increased plaque vulnerability even before the onset of
DM [27] and the larger visceral adipose tissue area is
associated with the vulnerable characteristics of coron-
ary plaques in patients without DM, but not in patients
with DM [28]. Therefore, it can be inferred IR and
abdominal obesity may be a significant cardio-metabolic
risk factor that is associated with plaque vulnerability
before the development of DM [28]. IR assessed by the
HOMA index during the acute phase of the first anterior
ST segment elevation MI in patients without diabetes
treated by primary PCI is independently associated
with poorer myocardial reperfusion, impaired coronary
microcirculatory function and potentially with larger
final infarct size [29]. Moreover, in patients with MetS, a
two- to three-fold increased risk of CAD and cardiovas-
cular mortality has been reported [30–32]. So, themediate remodeling Positive remodeling P-value
5 n = 153
63.38 ± 10.57 62.18 ± 11.73 0.688
5.3) 131 (70.8) 0.716
89.5 ± 6.6 90.3 ± 9.5 0.576
24.3 ± 2.8 25.1 ± 3.3 0.106
176.9 ± 43.5 180.5 ± 47.9 0.825
145.1 ± 93.6 146.2 ± 91.6 0.854
42.5 ± 10.0 41.5 ± 10.3 0.528
104.3 ± 37.4 107.8 ± 40.8 0.504
6.39 ± 1.09 6.67 ± 1.39 0.309
0.51 ± 1.02 0.67 ± 1.41 0.045
2.75 ± 2.26 3.55 ± 3.59 0.045
2.16 ± 1.14 2.23 ± 1.17 0.051
rotein





95% confidence interval p-value
Lower Upper
Age 0.034 −0.001 0.002 0.652
Sex −0.030 −0.050 0.034 0.706
Smoking 0.044 −0.021 0.038 0.563
MetS 0.045 −0.024 0.047 0.515
hsCRP 0.097 −0.004 0.027 0.157
HOMA-IR 0.166 0.001 0.003 0.018
MetS metabolic syndrome, hsCRP high sensitivity C-reactive protein
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coronary artery disease even though they have no history
of DM.
Several studies evaluated the poor outcome of coronary
artery disease in the patients of MetS or IR state, but little
is known about correlations between IR and coronary
artery remodeling associated with coronary plaques. This
study focused to demonstrate the coronary artery remod-
eling and IR. In the present study, remodeling index was
significantly higher in the HOMA-IR positive group com-
pared with negative group, and positive remodeling was
more common in the HOMA-IR positive group. As men-
tioned above, positively remodeled vessels with greater
plaque volume means increased lipid-rich components.
Therefore, our findings proposed that increased remodel-
ing index in the patients with IR are relevant to plaque
vulnerability, resulting in increased coronary events such
as plaque rupture. Our results are supported by the
findings of previous tissue characterization-IVUS studies
showing that plaque vulnerability is increased in patients
with IR [33]. Finally, based on our findings, it can be
inferred that the patient with IR would have more posi-
tively remodeled plaques than the patient without IR.
There are several limitations which need to be ac-
knowledged and addressed regarding this study. Firstly,
this study was a retrospective, cross-sectional study and
follow-up data were not available. Therefore, these re-
sults need to be validated by further studies with larger
samples. Secondly, severely calcified arteries, other com-
plex lesions and severely stenotic lesions, which might
show negative remodeling, were excluded from this study
due to limited assessment of coronary morphological
disturbances by IVUS. Therefore, the results of this study
might represent only a selected group of patients. This
could be the cause of the relatively large number of PR
patterns in our study.
Conclusions
In conclusion, increased IR estimated by HOMA-IR was
significantly associated with higher remodeling indexand positive coronary artery remodeling. The evaluation
of IR is important in the patients with coronary artery
disease even though they have no history of DM. Further
studies regarding effects of insulin resistance on coron-
ary artery remodeling will be needed to validate the
results of this study and to provide better understanding
about the natural history of atherosclerosis of coronary
arteries.
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